Atlas FDA

Cardiva VASCADE Family

FDA premarket approval P120016/S035 · decided 2024-01-08

Approval details

PMA number
P120016
Supplement
S035
Supplement type
Special (Immediate Track)
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Cardiva VASCADE Family
Generic name
Device, hemostasis, vascular
Applicant
Cardiva Medical, Inc.
Date received
2023-12-18
Decision date
2024-01-08
Days to decision
21 days
Decision code
APPR
Product code
MGB
Advisory committee
Cardiovascular
Expedited review
No
Location
Santa Clara, CA
Statement
Approval for adding a warning to the instructions for use related to retracting the device sleeve to enhance the safe use of the device

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
CATALYST II AND III (K130124)Cardiva Medical, Inc.2013-03-14
CARDIVA CATALYST III SYSTEM WITH PROTAMINE SULFATE (K082930)Cardiva Medical, Inc.2009-02-13
BOOMERANG CATALYST/BOOMERANG CATALYST II SYSTEM (K072297)Cardiva Medical, Inc.2007-09-12
BOOMERANG WIRE /BOOMERANG PLUS WIRE SYSTEM, MODEL# B PLUS WIRE 58L (K070485)Cardiva Medical, Inc.2007-03-22
BOOMERANG CLOSUREWIRE VASCULAR CLOSURE SYSTEM (K051817)Cardiva Medical, Inc.2006-12-06
BOOMERANG WIRE (K061075)Cardiva Medical, Inc.2006-09-01
VASOSTASIS VASCULAR CLOSURE SYSTEM (K041486)Cardiva Medical, Inc.2004-10-22